Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

TerminatedOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

January 25, 2017

Primary Completion Date

November 28, 2018

Study Completion Date

December 19, 2018

Conditions
Non-infectious Uveitis
Interventions
DRUG

dexamethasone intravitreal implant

Dexamethasone intravitreal implant (OZURDEX®) as prescribed in clinical practice.

Trial Locations (21)

13385

Hopital de la Timone, Marseille

21079

CHU Dijon, Dijon

31000

Chu Toulouse, Toulouse

33000

Centre Rétine Gallien, Bordeaux

33076

Hopital Pellegrin, Bordeaux

34000

Hopital Gui De Chauliac, Montpellier

44000

SEL Ophtalliance, Nantes

44093

Hopital Hotel Dieu Et Hme, Nantes

59037

Hopital Claude Huriez, Lille

69130

Centre Pôle Vision Val d'Ouest, Écully

69317

Hopital De La Croix Rousse, Lyon

75010

Hôpital Lariboisière (AP-HP), Paris

75013

GH Pitie Salpêtrière (AP-HP), Paris

75014

GH Cochin St Vincent De Paul (AP-HP), Paris

75019

Fondation Rothschild, Paris

80000

CHU Amiens, Amiens

IOP Institut Ophtalmologique de Picardie, Amiens

86021

Hopital La Milétrie, Poitiers

94000

CHI de Créteil, Créteil

13 008

Clinique Monticelli, Marseille

06000

CHU Pasteur 2, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY